Answers are grounded in this paper and cite their sources.
Robustness stress tests for clinical prediction models remove measurements and compare prediction error, but the outcomes used for that comparison may themselves be incompletely observed. We examined whether incomplete follow-up can distort the estimated effect of missing measurements. A controlled simulation separated measurement loss from censoring. A semi-synthetic experiment used SUPPORT clinical records divided by patient into development, validation and test sets of 5,416, 1,739 and 1,812 eligible records, retaining original known 180-day outcomes as a reference while artificial censoring was imposed. Five fixed prediction strategies and standard censoring-weighted estimators were evaluated. For indicator logistic regression, albumin-dependent measurement loss worsened reference Brier score by 0.00483, yet scoring only outcomes still known after albumin-driven censoring suggested an improvement of 0.00384. Masking-effect estimation error was ?0.00867 [?0.01033, ?0.00696] for known-outcome-only scoring and ?0.00167 [?0.00303, ?0.00017] for marginal inverse-probability-of-censoring weighting, conditional on the fitted source model; corresponding source-refitting validation intervals included zero. Other pipelines showed exaggerated rather than reversed deterioration. Exploratory hepatocellular carcinoma analyses in 165 UCI and 366 TCGA records motivated the study; their original augmentation contrast was inconclusive. Robustness evaluations should report how outcomes were observed and distinguish fixed-model from source-refitting uncertainty.
No takes yet. Share an insight, caveat, or question.
Massaoudy et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: